[1]
Leung, M.G.H. and Guilz, N. 2021. Using CRISPR-Cas9 to Target EGFRvIII and SIRP-ɑ for Glioblastoma Treatment . Journal of Student Research. 10, 4 (Nov. 2021). DOI:https://doi.org/10.47611/jsrhs.v10i4.2297.